
What We're Reading: Prevalence of Underlying Conditions; Opioid Label Change; ICE Detainees Held
New CDC data outline the prevalence of 5 common underlying health conditions that exacerbate coronavirus disease 2019 (COVID-19) symptoms; the FDA announced information regarding naloxone must be included on labels for opioids and opioid use disorder medications; despite a district judge's ruling nearly a month ago, hundreds of migrant detainees are being held in detention centers in states where COVID-19 cases are surging.
Data Highlight Prevalence of Underlying Health Conditions
Nearly 50% of American adults live with an underlying medical condition, strongly tied to severe coronavirus disease 2019 (COVID-19) outcomes, CIDRAP
Naloxone Information Required on Opioid Medication Labels
The FDA
Migrant Detainees Held in Facilities During COVID-19 Surge
Despite a judge’s order mandating their release, nearly 350 migrant parents and children remain in Immigration and Customs Enforcement (ICE) facilities with coronavirus outbreaks, The Hill
Related to this article








